IL-10, TNF-α & IFN-γ: Potential early biomarkers for preeclampsia

Cellular Immunology

Volumn 283, Issue 1-2, 2013, Pages 70-74

  Kumar, Ashok ^a   Begum, Nargis ^a   Prasad, Sudha ^a   Agarwal, Sarita ^a   Sharma, Shashi ^b  

^a LOK NAYAK HOSPITAL   (India)

^b INSTITUTE OF CYTOLOGY AND PREVENTIVE ONCOLOGY   (India)

Author keywords

Cytokines; IFN ; IL 10; Preeclampsia; Pregnancy

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CESAREAN SECTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELIVERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANT WOMAN; PRIMIGRAVIDA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; SERUM; VAGINAL DELIVERY;

CYTOKINES; IFN-Γ; IL-10; PREECLAMPSIA; PREGNANCY;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84880753037     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2013.06.012     Document Type: Article

References (39)

1. Hill J.A., Choi B.C. Maternal immunological aspects of pregnancy success and failure. J. Reprod. Fertil. 2000, (Suppl. 5):91-97.
2. Makhseed M., Raghupathy R., Azizieh F., Omu A., Al-Shamali E., Ashkanani L. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum. Reprod. 2001, 16:219-226.
3. Zhu X.Y., Zhou Y.H., Wang M.Y., Jin L.P., Yuan M.M., Li D.J. Blockade of CD86 signaling facilitates a Th2 bias at the maternal-fetal interface and expands peripheral CD4+CD25+ regulatory T cells to rescue abortion-prone foetuses. Biol. Reprod. 2005, 72:338-345.
4. Jenkins C., Roberts J., Wilson R., MacLean M.A., Shilito J., Walker J. Evidence of a Th1 type response associated with recurrent miscarriage. Fertil. Steril. 2000, 73:1206-1208.
5. Daher S., Shulzhenko N., Morgun A., Mattar R., Rampim G.F., Camano L., DeLima M.G. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J. Reprod. Immunol. 2003, 58:69-77.
6. Clark D.A., Croitoru K. Th1/Th2,3 imbalance due to cytokine producing NK, gamma delta T and NK-(δ) T cells in murine pregnancy decidua in success or failure of pregnancy. Am. J. Reprod. Immunol. 2001, 45:257-265.
7. Anim-Nyame N., Gamble J., Sooranna S.R., et al. Microarray permeability is related to circulating levels of tumour necrosis factor-α in preeclampsia. Cardiovasc. Res. 2003, 58:162-169.
8. Molvarec A., Jermendy A., Nagy B., Kovács M., Várkonyi T., Hupuczi P., Prohászka Z., Rigó J. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction. Clin. Chim. Acta 2008, 392:52-57.
9. Murphy S., Fast L., Sharma S. IL-10, uterine NK cells, inflammation, and pregnancy. Am. J. Reprod. Immunol. 2004, 51:434.
10. Henessy A., Pilmore H.L., Simmons L.A., et al. A deficiency of placental IL-10 in preeclampsia. J. Immunol. 1999, 163:3491-3495.
11. Roth I., Fisher S.J. IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev. Biol. 1999, 205:194-204.
12. Mansouri R., Akbari F., Vodjgani M., Mahboudi F., Kalantar F., Mirahmadian M. Serum cytokines profiles in Iranian patients with preeclampsia. Iran. J. Immunol. 2007, 4(3):179-185.
13. Jonsson Y., Rubèr M., Matthiesen L., Berg G., Nieminen K., Sharma S., Ernerudh J., Ekerfelt C. Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J. Reprod. Immunol. 2006, 70:83-91.
14. Mishra D., Singh H.P. Kuppuswamy's socio-economic status scale - a revision. Indian J. Pediatr. 2003, 70(3):273-274.
15. Diagnosis and management of preeclampsia and eclampsia. Obstet. Gynecol. 2002, 99:159-167. American College of Obstetricians and Gynecologists, [ACOG Practice Bulletin No. 33].
16. Houben M.L., Nikkels P.G., van Bleek G.M., Visser G.H., Rovers M.M., Kessel H., de Waal W.J., Schuijff L., Evers A., Kimpen J.L., Bont L. The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study. PLoS One 2009, 4:e6572.
17. Malamitsi-Puchner A., Protonotariou E., Boutsikou T., Makrakis E., Sarandakou A., Creatsas G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum. Dev. 2005, 81:387-392.
18. Keski-Nisula L., Hirvonen M.R., Roponen M., Heinonen S., Pekkanen J. Spontaneous and stimulated interleukin-6 and tumor necrosis factor-alpha production at delivery and three months after birth. Eur. Cytokine Network 2004, 15:67-72.
19. Steinborn A., Kühnert M., Halberstadt E. Immunmodulating cytokines induce term and preterm parturition. J. Perinat. Med. 1996, 24:381-390.
20. Serin I.S., Ozçelik B., Basbug M., Kiliç H., Okur D., Erez R. Predictive value of tumor necrosis factor alpha (TNF-α) in preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2002, 100:143-145.
21. Bamberg C., Fotopoulou C., Thiem D., Roehr C.C., Dudenhausen J.W., Kalache K.D. Correlation of mid trimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia. J. Matern. Fetal Neonatal Med. 2011, 25(6):812-817.
22. Liberman A.C., Refojo D., Arzt E. Cytokine signaling/transcription factor cross-talk in T cell activation and Th1-Th2 differentiation. Arch. Immunol. Ther. Exp. (Warsz) 2003, 51:351-365.
23. Matsuzaki J., Tsuji T., Imazeki I., Ikeda H., Nishimura T. Immunosteroid as a regulator for Th1/Th2 balance: it's possible role in autoimmune diseases. Autoimmunity 2005, 38:369-375.
24. Paulesu L., Romagnoli R., Cintorino M., Ricci M.G., Garotta G. First trimester human trophoblast expresses both interferon-gamma and interferon-gamma-receptor. J. Reprod. Immunol. 1994, 27:37-48.
25. Aziz A., Fréderic L., Paul B., Moutquin J.M. Maternal circulating interferon-g and interleukin-6 as biomarkers of Th1/Th2 immune status throughout pregnancy. J. Obstet. Gynaecol. Res. 2008, 34:7-11.
26. Wilczyński J.R., Tchórzewski H., Banasik M., Głowacka E., Wieczorek A., Lewkowicz P., Malinowski A., Szpakowski M., Wilczyński J. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003, 109:8-15.
27. Darmochwal-Kolarz D., Rolinski J., Leszczynska-Goarzelak B., Oleszczuk J. The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am. J. Reprod. Immunol. 2002, 48:381-386.
28. Borekci B., Aksoy H., Al R.A., Demircan B., Kadanali S. Maternal serum interleukin-10, interleukin-2 and interleukin-6 in pre-eclampsia and eclampsia. Am. J. Reprod. Immunol. 2007, 58:56-64.
29. Yoneyama Y., Suzuki S., Sawa R., Yoneyama K., Power G.G., Araki T. Relation between adenosine and T-helper 1/T-helper 2 imbalance in women with preeclampsia. Clin. Biochem. 2002, 35:303-306.
30. Vince G.S., Starkey P.M., Austgulen R., Kwiatkowski D., Redman C.W. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br. J. Obstet. Gynaecol. 1995, 102:20-25.
31. Conrad K.P., Miles T.M., Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am. J. Reprod. Immunol. 1998, 40:102-111.
32. Sibai B., Romero R., Klebanoff M.A., Rice M.M., et al. Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia. Am. J. Obstet. Gynecol. 2009, 200:e1-e8.
33. Hamai Y., Fujii T., Yamashita T., et al. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-alpha levels before the clinical manifestations of preeclampsia. Am. J. Reprod. Immunol. 1997, 38:89-93.
34. Bakheit K.H., Bayoumi N.K., Eltom A.M., Elbashir M.I., Adam I. Cytokines profiles in Sudanese women with preeclampsia. Hypertens. Pregnancy 2009, 28:224-229.
35. Azizieh F., Raghupathy R., Makhseed M. Maternal cytokine production patterns in women with pre-eclampsia. Am. J. Reprod. Immunol. 2005, 54:30-37.
36. Koçyigit Y., Atamer Y., Atamer A., Tuzcu A., Akkus Z. Changes in serum levels of leptin, cytokines and lipoprotein in pre-eclamptic and normotensive pregnant women. Gynecol. Endocrinol. 2004, 19:267-273.
37. Afshari J.T., Ghomian N., Shameli A., Shakeri M.T., Fahmidehkar M.A., Mahajer E., Khoshnavaz R., Emadzadeh M. Determination of interleukin-6 and tumor necrosis factor-alpha concentrations in Iranian-Khorasanian patients with preeclampsia. BMC Pregnancy Childbirth 2005, 5:14.
38. Szarka A., Rigo J., Lazar L., Beko G., Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010, 11:59.
39. Alanbay I., Coksuer H., Ercan C.M., Ustun Y., Pala G., Karasahin K.E., Ozturk O., Kurt I., Baser I. Chitotriosidase, interleukin-1 beta and tumor necrosis factor alpha levels in mild preeclampsia. Arch. Gynecol. Obstet. 2011, 285(6):1505-1511.